57124 Federal Register / Vol. 88, No. 161 / Tuesday, August 22, 2023 / Notices 

fulfill the duties of the Advisory 

Committee. The membership 

requirements are set forth in section 

2119 of the Public Health Service Act. 

ACCV consists of nine voting 

members appointed by the Secretary as 

follows: (1) three health professionals, 

who are not employees of the United 

States government, and who have 

expertise in the health care of children, 

the epidemiology, etiology, and 

prevention of childhood diseases, and 

the adverse reactions associated with 

vaccines, of whom at least two shall be 

pediatricians; (2) three members from 

the general public, of whom at least two 

shall be legal representatives (parents or 

guardians) of children who have 

suffered a vaccine-related injury or 

death; and (3) three attorneys, of whom 

at least one shall be an attorney whose 

specialty includes representation of 

persons who have suffered a vaccinerelated injury or death, and of whom 

one shall be an attorney whose specialty 

includes representation of vaccine 

manufacturers. In addition, the Director 

of the National Institutes of Health, the 

Assistant Secretary for Health, the 

Director of the Centers for Disease 

Control and Prevention, and the 

Commissioner of the Food and Drug 

Administration (or the designees of such 

officials) serve as nonvoting ex officio 

members. 

HHS will consider nominations of all 

qualified individuals to ensure the 

ACCV includes the areas of subject 

matter expertise noted above. As 

indicated above, at least two of the three 

ACCV members of the general public 

must be legal representatives (parents or 

guardians) of children who have 

suffered a vaccine-related injury or 

death. Because those members must be 

the legal representatives of children 

who have suffered a vaccine-related 

injury or death, to be considered for 

appointment to the ACCV in that 

category, there must have been a finding 

(i.e., a decision) by the U.S. Court of 

Federal Claims or a civil court that a 

VICP-covered vaccine caused, or was 

presumed to have caused, the 

represented child’s injury or death. 

Additionally, based on a 

recommendation made by ACCV, the 

Secretary will consider having a health 

professional with expertise in obstetrics 

as one of the members of the general 

public. Interested applicants may selfnominate or be nominated by another 

individual or organization. 

Individuals selected for appointment 

to ACCV will be invited to serve for 3 

years. Members are appointed as SGEs 

and receive a stipend and 

reimbursement for per diem and travel 

expenses incurred for attending ACCV 

meetings and/or conducting other 

business on behalf of ACCV, as 

authorized by 5 U.S.C. 5703 for persons 

employed intermittently in government 

service. 

The following information must be 

included in the package of materials 

submitted for each individual 

nominated for consideration: (1) a letter 

of nomination stating the name, 

affiliation, and contact information for 

the nominee, the basis for the 

nomination (i.e., what specific 

attributes, perspectives, and/or skills 

does the individual possess that would 

benefit the workings of the ACCV) and 

the nominee’s field(s) of expertise; (2) 

the name, address, daytime telephone 

number, and email address at which the 

nominator can be contacted; and (3) a 

current copy of the nominee’s 

curriculum vitae or resume. Nomination 

packages may be submitted directly by 

the individual being nominated or by 

the person/organization recommending 

the candidate. Nomination packages 

will be collected and retained to create 

a pool of possible future ACCV voting 

members. When a vacancy occurs, 

nomination packages from the 

appropriate category will be reviewed 

and nominees may be contacted at that 

time. 

HHS endeavors to ensure that ACCV’s 

membership is balanced in terms of 

points of view represented and that 

individuals from a broad representation 

of geographic areas, gender, and ethnic 

and minority groups, as well as 

individuals with disabilities, are 

considered for membership. 

Appointments shall be made without 

discrimination on the basis of age, 

disability, race, ethnicity, gender, sexual 

orientation, national origin, or cultural, 

religious, or socioeconomic status. 

Individuals who are selected to be 

considered for appointment will be 

required to provide detailed information 

regarding their financial holdings, 

consultancies, and research grants or 

contracts. Disclosure of this information 

is required for HRSA ethics officials to 

determine whether there is a potential 

conflict of interest between the SGE’s 

public duties as a member of ACCV and 

their private interests, including an 

appearance of a loss of impartiality as 

defined by federal laws and regulations, 

and to identify any required remedial 

action needed to address the potential 

conflict. 

Authority: Under the authorities that 

established the ACCV, the Federal 

Advisory Committee Act of October 6, 

1972, (Pub. L. 92–463, as amended) and 

the National Childhood Vaccine Injury 

Act (Pub. L. 99–660, as amended), 

HRSA is requesting nominations for 

voting members of ACCV. 

Maria G. Button, 

Director, Executive Secretariat. 

[FR Doc. 2023–17999 Filed 8–21–23; 8:45 am] 

BILLING CODE 4165–15–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Health Resources and Services 

Administration 

Notice of Award of President’s 

Emergency Plan for AIDS Relief 

(PEPFAR) Funding To Strengthen 

Health Workforce Efforts in the 

Democratic Republic of Congo (DRC) 

AGENCY: Health Resources and Services 

Administration (HRSA), Department of 

Health and Human Services. 

ACTION: Notice of award. 

SUMMARY: HRSA will award $2 million 

in PEPFAR funding for work in DRC to 

strengthen pre-service education 

primarily focusing on nursing and 

midwifery competencies through 

student clinical rotations and 

community health work. 

FOR FURTHER INFORMATION CONTACT: 

Carla Haddad, Director, Office of Global 

Health, HRSA, chaddad@hrsa.gov and 

(301) 443–4551. 

SUPPLEMENTARY INFORMATION: 

Intended Recipient of the Award: 

Johns Hopkins Program for International 

Education in Gynecology and Obstetrics 

(JHPIEGO) Global Reach II Program 

UH6OA45170. 

Amount of Awards: Two awards, 

$400,000 for Q4 FY2023 and $1,600,000 

for Q1–Q4 FY 2024, totaling $2,000,000. 

Project Period: July 1, 2023– 

September 30, 2024. 

CFDA Number: 93.266. 

Award Instrument: Cooperative 

Agreement Supplement. 

Authority: Public Law 108–25 (the 

United States Leadership Against HIV/ 

AIDS, Tuberculosis and Malaria Act of 

2003) [22 U.S.C. 7601 et seq.], Public 

Law 110–293 and Public Law 113–56. 


lotter on DSK11XQN23PROD with NOTICES1
Federal Register / Vol. 88, No. 161 / Tuesday, August 22, 2023 / Notices 57125 

TABLE 1—RECIPIENTS AND AWARD AMOUNTS

Grant No. Award recipient name Country Award amount 

UH6OA45170 ................................................. JHPIEGO Global Reach II .................................................................. DRC $400,000 

UH6OA45170 ................................................. JHPIEGO Global Reach II .................................................................. DRC 1,600,000 

Justification: DRC continues to face 

severe shortages of nurses and nursemidwives for HIV prevention, care and 

treatment and essential health services, 

and this award is critical for HIV 

epidemic control and health security in 

DRC. The recipient is implementing 

similar efforts to strengthen the health 

workforce in other countries (Uganda, 

Ethiopia, and Zambia) with strong 

progress and outcomes. 

Carole Johnson, 

Administrator. 

[FR Doc. 2023–18001 Filed 8–21–23; 8:45 am] 

BILLING CODE 4165–15–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute on Alcohol Abuse 

and Alcoholism; Notice of Closed 

Meetings 

Pursuant to section 1009 of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute on 

Alcohol Abuse and Alcoholism Special 

Emphasis Panel; Ruth L. Kirschstein 

Institutional National Research Service 

Award Review. 

Date: September 25, 2023. 

Time: 1:00 p.m. to 4:30 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

National Institute on Alcohol Abuse and 

Alcoholism, 6700B Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Beata Buzas, Ph.D., 

Scientific Review Officer, Extramural Project 

Review Branch, Office of Extramural 

Activities, National Institute on Alcohol 

Abuse and Alcoholism, 6700B Rockledge 

Drive, Room 2116, MSC 6902, Bethesda, MD 

20817, (301) 443–0800, bbuzas@mail.nih.gov. 

Name of Committee: National Institute on 

Alcohol Abuse and Alcoholism Initial 

Review Group Neuroscience and Behavior 

Study Section. 

Date: October 25, 2023. 

Time: 10:00 a.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institute of Health, 

National Institute on Alcohol Abuse and 

Alcoholism, 6700B Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Beata Buzas, Ph.D., 

Scientific Review Officer, Extramural Project 

Review Branch, Office of Extramural 

Activities, National Institute on Alcohol 

Abuse and Alcoholism, 6700B Rockledge 

Drive, Room 2116, MSC 6902, Bethesda, MD 

20817, 301–443–0800, bbuzas@mail.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.273, Alcohol Research 

Programs, National Institutes of Health, HHS) 

Dated: August 17, 2023. 

Melanie J. Pantoja, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2023–18037 Filed 8–21–23; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HOMELAND 

SECURITY 

Federal Emergency Management 

Agency 

[Docket ID FEMA–2014–0022] 

Technical Mapping Advisory Council; 

Meeting 

AGENCY: Federal Emergency 

Management Agency, Department of 

Homeland Security. 

ACTION: Notice of Federal advisory 

committee meeting. 

SUMMARY: The Federal Emergency 

Management Agency (FEMA) Technical 

Mapping Advisory Council (TMAC) will 

hold an in-person public meeting with 

a virtual option on Tuesday, September 

19, 2023, and Wednesday, September 

20, 2023. The meeting will be open to 

the public in-person and via a Microsoft 

Teams Video Communications link. 

DATES: The TMAC will meet on 

Tuesday, September 19, 2023, and 

Wednesday, September 20, 2023, from 

8:00 a.m. to 5:00 p.m. Eastern Time 

(ET). Please note that the meeting will 

close early if the TMAC has completed 

its business. 

ADDRESSES: The meeting will be held inperson at the FEMA Conference Center 

at 400 C St. SW, Washington, DC 20472. 

and virtually using the following 

Microsoft Teams Video 

Communications link (Tuesday Link: 

https://tinyurl.com/5n7ahwpw; 

Wednesday Link: https://tinyurl.com/ 

bdjetjb9). Members of the public who 

wish to attend the in-person or virtual 

meeting must register in advance by 

sending an email to FEMA-TMAC@

fema.dhs.gov (Attn: Brian Koper) by 

5:00 p.m. ET on Friday, September 15, 

2023. Members of the public who wish 

to attend the in-person or virtual 

meeting must register in advance by 

sending an email to FEMA-TMAC@

fema.dhs.gov (Attn: Brian Koper) by 

5:00 p.m. ET on Friday, September 15, 

2023. 

To facilitate public participation, 

members of the public are invited to 

provide written comments on the issues 

to be considered by the TMAC, as listed 

in the SUPPLEMENTARY INFORMATION

caption below. Associated meeting 

materials will be available upon request 

after Wednesday, September 13, 2023. 

To receive a copy of any relevant 

materials, please send the request to: 

FEMA-TMAC@fema.dhs.gov (Attn: 

Brian Koper). Written comments to be 

considered by the committee at the time 

of the meeting must be submitted and 

received by Thursday, September 14, 

2023, 5:00 p.m. ET identified by Docket 

ID FEMA–2014–0022, and submitted by 

one of the following methods: 

• Federal eRulemaking Portal: http:// 

www.regulations.gov. Follow the 

instructions for submitting comments. 

• Email: Address the email to FEMATMAC@fema.dhs.gov. Include the 

docket number in the subject line of the 

message. Include name and contact 

information in the body of the email. 

Instructions: All submissions received 

must include the words ‘‘Federal 

Emergency Management Agency’’ and 

the docket number for this action. 

Comments received will be posted 

without alteration at http://

www.regulations.gov, including any 

personal information provided. You 

may wish to review the Privacy and 

Security Notice via a link on the 

homepage of www.regulations.gov. 


lotter on DSK11XQN23PROD with NOTICES1